307 related articles for article (PubMed ID: 26048580)
21. Randomized open-label trial of baclofen for relapse prevention in alcohol dependence.
Gupta M; Verma P; Rastogi R; Arora S; Elwadhi D
Am J Drug Alcohol Abuse; 2017 May; 43(3):324-331. PubMed ID: 27808555
[TBL] [Abstract][Full Text] [Related]
22. High-dose baclofen for treatment-resistant alcohol dependence.
Pastor A; Jones DM; Currie J
J Clin Psychopharmacol; 2012 Apr; 32(2):266-8. PubMed ID: 22367662
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of disulfiram for the treatment of alcohol dependence assessed with a multicenter randomized controlled trial.
Yoshimura A; Kimura M; Nakayama H; Matsui T; Okudaira F; Akazawa S; Ohkawara M; Cho T; Kono Y; Hashimoto K; Kumagai M; Sahashi Y; Roh S; Higuchi S
Alcohol Clin Exp Res; 2014 Feb; 38(2):572-8. PubMed ID: 24117666
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study.
Berger L; Fisher M; Brondino M; Bohn M; Gwyther R; Longo L; Beier N; Ford A; Greco J; Garbutt JC
Alcohol Clin Exp Res; 2013 Apr; 37(4):668-74. PubMed ID: 23134193
[TBL] [Abstract][Full Text] [Related]
25. Efficacy, tolerability, and safety of low-dose and high-dose baclofen in the treatment of alcohol dependence: A systematic review and meta-analysis.
Pierce M; Sutterland A; Beraha EM; Morley K; van den Brink W
Eur Neuropsychopharmacol; 2018 Jul; 28(7):795-806. PubMed ID: 29934090
[TBL] [Abstract][Full Text] [Related]
26. A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence.
Anton RF; Kranzler H; Breder C; Marcus RN; Carson WH; Han J
J Clin Psychopharmacol; 2008 Feb; 28(1):5-12. PubMed ID: 18204334
[TBL] [Abstract][Full Text] [Related]
27. Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection.
Leggio L; Ferrulli A; Zambon A; Caputo F; Kenna GA; Swift RM; Addolorato G
Addict Behav; 2012 Apr; 37(4):561-4. PubMed ID: 22244707
[TBL] [Abstract][Full Text] [Related]
28. Comparison of disulfiram and placebo in treatment of alcohol dependence of adolescents.
Niederhofer H; Staffen W
Drug Alcohol Rev; 2003 Sep; 22(3):295-7. PubMed ID: 15385223
[TBL] [Abstract][Full Text] [Related]
29. Treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebo-controlled trial.
Lyon JE; Khan RA; Gessert CE; Larson PM; Renier CM
J Hosp Med; 2011 Oct; 6(8):469-74. PubMed ID: 21990176
[TBL] [Abstract][Full Text] [Related]
30. The dose-effect relationship of baclofen in alcohol dependence: A 1-year cohort study.
Pignon B; Labreuche J; Auffret M; Gautier S; Deheul S; Simioni N; Cottencin O; Bordet R; Duhamel A; Rolland B
Hum Psychopharmacol; 2017 Jul; 32(4):. PubMed ID: 28517239
[TBL] [Abstract][Full Text] [Related]
31. Baclofen for the Treatment of Alcohol Dependence and Possible Role of Comorbid Anxiety.
Morley KC; Baillie A; Leung S; Addolorato G; Leggio L; Haber PS
Alcohol Alcohol; 2014 Nov; 49(6):654-60. PubMed ID: 25246489
[TBL] [Abstract][Full Text] [Related]
32. Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial.
Morley KC; Baillie A; Fraser I; Furneaux-Bate A; Dore G; Roberts M; Abdalla A; Phung N; Haber PS
Br J Psychiatry; 2018 Jun; 212(6):362-369. PubMed ID: 29716670
[TBL] [Abstract][Full Text] [Related]
33. Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence.
Addolorato G; Caputo F; Capristo E; Colombo G; Gessa GL; Gasbarrini G
Alcohol Clin Exp Res; 2000 Jan; 24(1):67-71. PubMed ID: 10656195
[TBL] [Abstract][Full Text] [Related]
34. Baclofen for alcohol use disorder-a systematic meta-analysis.
Bschor T; Henssler J; Müller M; Baethge C
Acta Psychiatr Scand; 2018 Sep; 138(3):232-242. PubMed ID: 29888478
[TBL] [Abstract][Full Text] [Related]
35. Neuroendocrine response to GABA-B receptor agonism in alcohol-dependent individuals: Results from a combined outpatient and human laboratory experiment.
Farokhnia M; Sheskier MB; Lee MR; Le AN; Singley E; Bouhlal S; Ton T; Zhao Z; Leggio L
Neuropharmacology; 2018 Jul; 137():230-239. PubMed ID: 29665351
[TBL] [Abstract][Full Text] [Related]
36. The efficacy of the dopamine D2/D3 antagonist tiapride in maintaining abstinence: a randomized, double-blind, placebo-controlled trial in 299 alcohol-dependent patients.
Bender S; Scherbaum N; Soyka M; Rüther E; Mann K; Gastpar M
Int J Neuropsychopharmacol; 2007 Oct; 10(5):653-60. PubMed ID: 17076934
[TBL] [Abstract][Full Text] [Related]
37. Moderation of baclofen response by a GABA
Morley KC; Luquin N; Baillie A; Fraser I; Trent RJ; Dore G; Phung N; Haber PS
Addiction; 2018 Dec; 113(12):2205-2213. PubMed ID: 29968397
[TBL] [Abstract][Full Text] [Related]
38. Utilization of baclofen in maintenance of alcohol abstinence in patients with alcohol dependence and alcoholic hepatitis with or without cirrhosis.
Yamini D; Lee SH; Avanesyan A; Walter M; Runyon B
Alcohol Alcohol; 2014; 49(4):453-6. PubMed ID: 24939964
[TBL] [Abstract][Full Text] [Related]
39. Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta-analysis.
Rose AK; Jones A
Addiction; 2018 Aug; 113(8):1396-1406. PubMed ID: 29479827
[TBL] [Abstract][Full Text] [Related]
40. Randomized, double-blind, placebo-controlled trial of vigabatrin for the treatment of cocaine dependence in Mexican parolees.
Brodie JD; Case BG; Figueroa E; Dewey SL; Robinson JA; Wanderling JA; Laska EM
Am J Psychiatry; 2009 Nov; 166(11):1269-77. PubMed ID: 19651710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
